Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of platelet function following cessation of ticagrelor in acute coronary syndrome patients with PCI and stent
2012-000665-20Phase 4Terminated
- Sponsor
- Universitetssjukhuset Örebro
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ticagrelor in acute coronary syndrome (ACS) and coronary arteriosclerosis, sponsored by Universitetssjukhuset Örebro. Primary endpoint: Time to normalization of platelet function after ticagrelor cessation. Started Feb 2012; status: terminated.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)coronary arteriosclerosis
Beyond the preview
Go deeper on 2012-000665-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000665-20.